Tetrandrine pharmaceutical formulations
US9259420B2 · kind B2 · utility
0Cited by
5References
5Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 12, 2013 |
| Grant date | Feb 16, 2016 |
| Priority date | — |
| Expiry date | Sep 12, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/38
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Drug formulations, methods and their use in treatment of diseases using the free base formulations of tetrandrine family members, especially d-tetrandrine, combined with a pharmaceutical diluent or carrier.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.